Loading...
Publication: Lopinavir-Ritonavir (LPV/r) for treament of COVID-19: Evidence review of clinical benefits and harms
Parrish, A Gray, A Kredo, T Maartens, G Reubenson, G Cohen, K De Waal, R Blockman, M Nel, J Rees, H
Parrish, A
Gray, A
Kredo, T
Maartens, G
Reubenson, G
Cohen, K
De Waal, R
Blockman, M
Nel, J
Rees, H
Citations
Altmetric:
Abstract
Description
The combination of lopinavir and ritonavir is used with other medications to treat human immunodeficiency virus (HIV) infection. Lopinavir and ritonavir are in a class of medications called protease inhibitors.
Date
2020-04-22
Journal Title
Journal ISSN
Volume Title
Publisher
South African National Department of Health
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Lopinavir-Ritonavir,Lopinavir-Ritonavir for treatment of COVID-19,Evidence review,Protease Inhibitor,Medicine,Immunology,Biology